The secret to slowing down aging might finally be upon us—but it sounds like the premise of a horror movie.
The biotech startup Ambrosia claims it has hit on a fountain of youth—a blood fountain, that is—with transfusions for older adults from people under the age of 25.
Founder Jesse Karmazin believes that young blood actually does have health benefits for older adults and is charging about $8,000 for a blood transfusion.
Though it may sound nutty, at the Recode Conference in Rancho Palos Verdes, California Karmazain said about 100 people have already signed up to receive an infusion.
Anyone over the age of 35 can become a customer, but Karmazin said most of the early adopters tend to be of retirement age. He also said that it’s a range of people, not just Bay Area technologists, who have signed up for the transfusions.
Ambrosia buys its supply from blood banks, who also sell blood to pharmaceutical companies. Karmazin stressed that the transfusions do not cure aging, but that it is an experiment to study if the anti-aging method will actually work.
This article was featured in the InsideHook newsletter. Sign up now.
